ArticleCNS neuroscience & therapeutics2025

Development of In Vitro Parkinson's Disease Model Mediated by MPP+ and α-Synuclein Using Wharton's Jelly Mesenchymal Stem Cells.

Naisarg Gamit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.